STOCK TITAN

ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
ESSA Pharma Inc. will be participating in a virtual fireside chat at the Oppenheimer 34th Annual Healthcare Life Sciences Conference. The company's President, CEO, COO, and CFO will host and participate in one-on-one meetings. The live webcast can be accessed on ESSA's website, and it will be archived for 90 days after the event.
Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Feb. 6, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be participating in a virtual fireside chat at the Oppenheimer 34th Annual Healthcare Life Sciences Conference on Tuesday, February 13, 2024, at 12:40 p.m. ET.

David. R. Parkinson, President, and Chief Executive Officer; Peter Virsik, Chief Operating Officer; and David S. Wood, Chief Financial Officer, will host and participate in one-on-one meetings.

A live webcast of the fireside chat can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the event, the webcast will be archived on the ESSA website for 90 days.

About ESSA Pharma Inc.

ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com, and follow us on Twitter and LinkedIn.

Contacts

ESSA Pharma, Inc.
Peter Virsik, Chief Operating Officer
778.331.0962
pvirsik@essapharma.com 

Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com

Cision View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-oppenheimer-34th-annual-healthcare-life-sciences-conference-302054080.html

SOURCE ESSA Pharma Inc

FAQ

When is ESSA Pharma Inc. participating in the Oppenheimer 34th Annual Healthcare Life Sciences Conference?

ESSA Pharma Inc. will be participating in the conference on Tuesday, February 13, 2024, at 12:40 p.m. ET.

Who will be hosting and participating in one-on-one meetings at the conference?

David R. Parkinson, President, and Chief Executive Officer; Peter Virsik, Chief Operating Officer; and David S. Wood, Chief Financial Officer will host and participate in one-on-one meetings.

Where can the live webcast of the fireside chat be accessed?

The live webcast can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com.

How long will the webcast be archived on the ESSA website?

The webcast will be archived on the ESSA website for 90 days after the event.

ESSA Pharma Inc.

NASDAQ:EPIX

EPIX Rankings

EPIX Latest News

EPIX Stock Data

304.36M
24.60M
2.27%
78.66%
1.81%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
VANCOUVER

About EPIX

as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in our approach. we're firmly rooted in creative and open thinking, giving us an energy and approach that makes us a different kind of pharmaceutical company.